Drug
Apoc Iii L RX
Apoc Iii L RX: highest development phase Phase 1, developed by Ionis Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Ionis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| APOC-III-L-Rx NCT02900027 | Phase 1 | Elevated Triglycerides (TG) |
Latest
No recent events.
Follow Apoc Iii L RX on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.